The RENOLIT Group extends its position in the global market of medical film activities by acquiring the medical film and related activities of AUSTAR PMC, which becomes part of the Business Unit RENOLIT MEDICAL.
This acquisition includes AUSTAR PMC’s film, tubing, ports and caps businesses manufactured in two production facilities located in Huairu and Tongzhou zone in the greater area of Beijing, China. All other activities of AUSTAR PMC are not part of the acquisition.
Mr. Mars Ho, currently CEO and major shareholder of AUSTAR PMC will remain CEO of the acquired entity with the objective and commitment to organize a seamless integration of AUSTAR Medical Film Division into the RENOLIT Group while ensuring relationship and service continuity to customers.
“AUSTAR Medical Film Division represents a key asset for the further development of RENOLIT’s medical business”, stated Pierre Winant, COO of RENOLIT. ”This strategic acquisition enables our Business Unit RENOLIT MEDICAL, in alignment with the vision of RENOLIT Group, to expand its product and technical portfolio, to increase its production and research competencies and to reinforce its presence in China where RENOLIT amongst others already produces films for blood sets in its Guangzhou manufacturing facility”, explained Winant.
“The acquisition will enhance the development and core-competency of the AUSTAR PMC’s purchased film, tubing, ports and caps business activities within RENOLIT MEDICAL thanks to the product, commercial and industrial complementarities, but also to the convergence of our strategic views. This will not only benefit our customers with better products and services but also all the involved employees of AUSTAR Medical Film Division”, added Mars Ho.
With the AUSTAR Medical Film Division acquisition, RENOLIT reinforces its medical business as a global partner with a balanced industrial and commercial presence in Europe, North America and Asia. By offering the widest range of film manufacturing technologies and products, the combined entity will extend RENOLIT MEDICAL’s value proposition to its valued and prospective customers.
The RENOLIT Group is an international leader in the manufacture of high-quality plastic films and related products for technical applications. This independent family-run business, which has been setting benchmarks for quality and innovation for over 65 years, now employs a workforce of approximately 4,000 employees at more than 30 production sites and sales companies.
For more than 10 years, AUSTAR Medical Film Division is a leading manufacturer of high-quality medical film material, tubings, ports and caps and medical resin for applications for infusion and dialysis solutions. AUSTAR Medical Film Division enjoys a worldwide reputation recognized by customers from America, Europe, Middle East and Asia and currently employs more than 400 people.
For editorial questions, please contact:
Head of Corporate Communications
Tel.: + 49 6241.303.295
Fax: + 49 6241.303.393